$0
0 item(s) in the shopping cart

Improve a company’s sustainability performance
By using the world’s most comprehensive CSR metrics database and analysis tools

ViroPharma Incorporated CSR Ratings

58
CSR Rating Compared To All Companies
?
Community
61
Employees
57
Environment
64
Governance
49
Low
0-29
30-39
40-49
50-59
60-79
80-100
High
?
CSR Rating History
This company vs 15,570 companies
The average for the 415 companies in the Pharmaceutical & Medicine Manufacturing industry
?

0 Special Issues

Affect This Company

?
5
Active Sources
6 Total Sources
?
Share This Summary

ViroPharma Incorporated is an international biopharmaceutical company focused on developing and commercializing products that address unmet medical needs.The company provides products to physician specialists that support patients with serious diseases, including disease caused by C1 esterase inhibitor deficiency, C. difficile, and cytomegalovirus (CMV). The company markets Cinryze for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE), a rare and potentially life threatening genetic inflammatory disorder; and Vancocin, an antibiotic approved to treat two significant bacterial infections of the lower digestive tract.

Ticker: VPHM
ISIN: US9282411084
Address:

397 Eagleview Boulevard

  Exton, PA, 19341, USA
Website: ViroPharma Incorporated
Phone #: 610-458-7300
CSR Web Area: Subscribers Only ?
Industry: Pharmaceutical & Medicine Manufacturing
PRIORITIES
Community
2.6
Employees
2.8
Environment
3.7
Governance
2.9
Edit your profiles
SWITCH PROFILE
Data Date
December 01, 2015
0 SPECIAL ISSUES SELECTED
CSRHub Subscribers Get Much More
CSRHub subscribers gain unparalleled and direct access to over 91 million data items, our easy-to-use suite of benchmarking and comparison tools, as well as our popular custom excel dashboards.
Access CSRHub's Premium Features